{"id":62623,"date":"2026-02-10T10:06:42","date_gmt":"2026-02-10T09:06:42","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\/"},"modified":"2026-02-10T10:06:42","modified_gmt":"2026-02-10T09:06:42","slug":"new-zoll-zenix-monitor-defibrillator-receives-mdr-approval","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\/","title":{"rendered":"New ZOLL Zenix Monitor\/Defibrillator Receives MDR Approval"},"content":{"rendered":"
\n

CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL\u00ae, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix\u00ae, the company\u2019s most clinically advanced and easy-to-use professional monitor\/defibrillator, is approved under the European Union (EU) Medical Device Regulation 2017\/745, commonly referred to as EU MDR.<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe Zenix monitor\/defibrillator is a groundbreaking device that redefines efficiency, clarity, and intelligence in both EMS and hospital settings. Built from years of feedback from customers, Zenix combines intuitive design with powerful functionality to enhance patient care and automate workflows for ease-of-use. Featuring a large, durable touchscreen, Zenix provides critical information when it\u2019s needed. With on-the-fly customization, healthcare professionals can make real-time adjustments, helping them stay in control during high-pressure situations.<\/p>\n

\nEquipped with ZOLL\u2019s innovative Real BVM Help\u00ae and exclusive Real CPR Help\u00ae technology, Zenix gives healthcare providers real-time clinical feedback to improve ventilation quality and deliver high-quality CPR.1<\/sup> The advanced technology of Zenix empowers EMS teams and hospital clinicians to make informed, confident decisions and ensure they are delivering exceptional patient care, every time.<\/p>\n

\n\u201cWhether you are a hospital clinician or an EMS professional, the ZOLL Zenix monitor\/defibrillator is designed to work the way you work,\u201d said Elijah White, President of ZOLL Acute Care Technology. \u201cZenix is our most advanced monitor\/defibrillator, and yet it\u2019s incredibly easy to use\u2014virtually all functions of the device are accessible with three screen-touches or less. Along with the X Series\u00ae, R Series\u00ae and ZOLL M2\u00ae, Zenix extends ZOLL\u2019s leadership in professional monitors\/defibrillators with unique features and intuitive design.\u201d<\/p>\n

\nFor more information, visit www.zoll.com\/zenix<\/a>.<\/p>\n

\nAbout ZOLL<\/b><\/p>\n

\nZOLL, an Asahi Kasei company, develops and markets medical devices and software solutions that help advance care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and cardiac monitoring, circulation enhancement and CPR feedback, supersaturated oxygen therapy, data management, ventilation, therapeutic temperature management, and sleep apnea diagnosis and treatment, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, as well as lay rescuers, improve patient outcomes in critical cardiopulmonary conditions. For more information, visit www.zoll.com<\/a>.<\/p>\n

\nAbout Asahi Kasei<\/b><\/p>\n

\nThe Asahi Kasei Group contributes to life and living for people around the world. Since its foundation in 1922 with ammonia and cellulose fiber businesses, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With 50,000 employees worldwide, the company contributes to a sustainable society by providing solutions to the world’s challenges through its three business sectors of Healthcare, Homes, and Material. Its healthcare operations include devices and systems for critical care, products and services for the manufacture of biotherapeutics, and a growing portfolio of specialty pharmaceuticals. For more information, visit www.asahi-kasei.com<\/a>.<\/p>\n

\nAsahi Kasei is also dedicated to sustainability initiatives and is contributing to reaching a carbon neutral society by 2050. To learn more, visit www.asahi-kasei.com\/sustainability\/<\/a>.<\/p>\n\n\n
\n

\n1<\/sup> Drennan et al. 10.1016\/j.resuscitation.2024.110381. https:\/\/pubmed.ncbi.nlm.nih.gov\/39299509\/<\/a><\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nCopyright \u00a9 2026 ZOLL Medical Corporation. All rights reserved. ZOLL, Zenix, Real BVM Help, Real CPR Help, X Series, R Series and M2 are registered trademarks of ZOLL Medical Corporation and\/or its subsidiaries in the United States and\/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All other trademarks are the property of their respective owners.<\/p>\n

Contacts<\/b> <\/p>\n

\nMatt Hogan
\n
ZOLL
\n
978-805-6561
\n
media@zoll.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL\u00ae, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix\u00ae, the company\u2019s most clinically advanced and easy-to-use professional monitor\/defibrillator, is approved under the European Union (EU) Medical Device Regulation 2017\/745, commonly referred to as EU MDR. The Zenix monitor\/defibrillator is a groundbreaking device that redefines efficiency, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62623","6":"format-standard","7":"category-industry"},"yoast_head":"\nNew ZOLL Zenix Monitor\/Defibrillator Receives MDR Approval - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New ZOLL Zenix Monitor\/Defibrillator Receives MDR Approval - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL\u00ae, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix\u00ae, the company\u2019s most clinically advanced and easy-to-use professional monitor\/defibrillator, is approved under the European Union (EU) Medical Device Regulation 2017\/745, commonly referred to as EU MDR. The Zenix monitor\/defibrillator is a groundbreaking device that redefines efficiency, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-10T09:06:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260210764283\/en\/2715659\/22\/ZOLL_Logo_Web_RGB_Blue_Rectangle_AK_%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"New ZOLL Zenix Monitor\\\/Defibrillator Receives MDR Approval\",\"datePublished\":\"2026-02-10T09:06:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\\\/\"},\"wordCount\":580,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260210764283\\\/en\\\/2715659\\\/22\\\/ZOLL_Logo_Web_RGB_Blue_Rectangle_AK_%281%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\\\/\",\"name\":\"New ZOLL Zenix Monitor\\\/Defibrillator Receives MDR Approval - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260210764283\\\/en\\\/2715659\\\/22\\\/ZOLL_Logo_Web_RGB_Blue_Rectangle_AK_%281%29.jpg\",\"datePublished\":\"2026-02-10T09:06:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260210764283\\\/en\\\/2715659\\\/22\\\/ZOLL_Logo_Web_RGB_Blue_Rectangle_AK_%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260210764283\\\/en\\\/2715659\\\/22\\\/ZOLL_Logo_Web_RGB_Blue_Rectangle_AK_%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New ZOLL Zenix Monitor\\\/Defibrillator Receives MDR Approval\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New ZOLL Zenix Monitor\/Defibrillator Receives MDR Approval - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\/","og_locale":"en_US","og_type":"article","og_title":"New ZOLL Zenix Monitor\/Defibrillator Receives MDR Approval - Pharma Trend","og_description":"CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL\u00ae, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix\u00ae, the company\u2019s most clinically advanced and easy-to-use professional monitor\/defibrillator, is approved under the European Union (EU) Medical Device Regulation 2017\/745, commonly referred to as EU MDR. The Zenix monitor\/defibrillator is a groundbreaking device that redefines efficiency, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\/","og_site_name":"Pharma Trend","article_published_time":"2026-02-10T09:06:42+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260210764283\/en\/2715659\/22\/ZOLL_Logo_Web_RGB_Blue_Rectangle_AK_%281%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"New ZOLL Zenix Monitor\/Defibrillator Receives MDR Approval","datePublished":"2026-02-10T09:06:42+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\/"},"wordCount":580,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260210764283\/en\/2715659\/22\/ZOLL_Logo_Web_RGB_Blue_Rectangle_AK_%281%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\/","url":"https:\/\/pharma-trend.com\/en\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\/","name":"New ZOLL Zenix Monitor\/Defibrillator Receives MDR Approval - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260210764283\/en\/2715659\/22\/ZOLL_Logo_Web_RGB_Blue_Rectangle_AK_%281%29.jpg","datePublished":"2026-02-10T09:06:42+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260210764283\/en\/2715659\/22\/ZOLL_Logo_Web_RGB_Blue_Rectangle_AK_%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260210764283\/en\/2715659\/22\/ZOLL_Logo_Web_RGB_Blue_Rectangle_AK_%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/new-zoll-zenix-monitor-defibrillator-receives-mdr-approval\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"New ZOLL Zenix Monitor\/Defibrillator Receives MDR Approval"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62623","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62623"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62623\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62623"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62623"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62623"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}